Award

Highly sensitive fecal DNA testing in combination with fecal immunochemical test for hemoglobin is a promising marker for detection of colorectal neoplasia

Description: The main approach to colorectal cancer screening worldwide is the fecal immunochemical test for hemoglobin (FIT). Although the sensitivity of the FIT for the diagnosis of colorectal neoplasia is about 90% for colorectal cancer, it falls to about 30% for the detection of advanced adenoma. To avoid this disadvantage, more sensitive methods are required. Therefore, we developed a new fecal DNA test. Sensitivity of the FIT alone was 38% for advanced adenoma, whereas sensitivity of the fecal DNA test and fecal DNA test combined was 66% for advanced adenoma, and specificity was 80%. Combination of the fecal DNA test with FIT may provide an alternative screening strategy for colorectal neoplasia, especially for potentially precancerous lesions.
Amount: ¥4,810,000
Funding type: research
Funder scheme: Grant-in-Aid for Scientific Research (C)
Start date: 2016-04-01
End date: 2019-03-31
Investigator: Yutaka SUEHIRO (lead)
Subfield: Oncology
Field: Medicine
Funded outputs count: 1
Funder award ID: 16K08969
OpenAlex ID: G3253674119
2017 · Yutaka Suehiro, Yibo Zhang, et al. · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · 30